Case Report

Glossopharyngeal Dystonia Secondary to a Lurasidone-Fluoxetine CYP-3A4 Interaction

Table 1

CYP 3A4 substrates, inhibitors, and inducers.

CYP enzymeSubstratesInhibitorsaInducers

3A4Alprazolam, amiodarone, amitriptyline, bastemizole, bupropion, caffeine, bcarbamazepine, cisapride, clarithromycin, clonazepam, codeine, bcortisol, cyclosporin, dapsone, bdesmethyldiazepam, bdiazepam, bdiltiazem, erythromycin, estradiol, ethinylestradiol, fluoxetine, haloperidol, bimipramine, blidocaine, loratadine, lovastatin, midazolam, nefazodone, nicardipine, nifedipine, omeprazole, bondansetron, orphenadrine, progesterone, quinidine, rifampin, sertraline, tamoxifen, terfenadine, testosterone, trazodone, triazolam, venlafaxine, bverapamil, and bzolpidemCimetidine, erythromycin, fluoxetine, fluvoxamine, indinavir, ketoconazole, naringenin, nefazodone, ritonavir, saquinavir, and sertraline (weak)Barbiturates, carbamazepine, dexamethasone, phenytoin, rifampin, and St. John's wort

Inhibitory potency varies greatly. bMore than one CYP enzyme is known to be involved in the metabolism of these drugs.5
Reprinted with permission from the American Psychiatric Publishing Textbook of Psychopharmacology (Copyright 2009), American Psychiatric Association.6